Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
73.00
+1.40 (1.96%)
At close: Jul 6, 2026
40.93% (1Y)
| Market Cap | 7.84B +50.2% |
| Revenue (ttm) | 10.57B +24.8% |
| Net Income | 606.13M +35.3% |
| EPS | 5.60 +34.4% |
| Shares Out | 107.42M |
| PE Ratio | 13.02 |
| Forward PE | n/a |
| Dividend | 1.40 (1.96%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 1,823,846 |
| Open | n/a |
| Previous Close | 71.60 |
| Day's Range | 71.90 - 73.80 |
| 52-Week Range | 45.50 - 78.00 |
| Beta | 0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |